Dachaigh › Leukemia Cealla-B
Sgrùdaidhean clionaigeach Leukemia Cealla-B a’ fastadh anns na SA
Tha 17 sgrùdaidhean airson Leukemia Cealla-B a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Houston, TX7 sgrùdaidhean
- Washington, DC5 sgrùdaidhean
- Dallas, TX5 sgrùdaidhean
- Portland, OR4 sgrùdaidhean
- Columbus, OH4 sgrùdaidhean
- Spokane, WA3 sgrùdaidhean
- Chicago, IL3 sgrùdaidhean
- Denver, CO3 sgrùdaidhean
- San Diego, CA3 sgrùdaidhean
- Pittsburgh, PA3 sgrùdaidhean
- Louisville, KY3 sgrùdaidhean
- Edison, NJ3 sgrùdaidhean
- Boston, MA3 sgrùdaidhean
- New York City, NY3 sgrùdaidhean
- Philadelphia, PA3 sgrùdaidhean
- Charlotte, NC3 sgrùdaidhean
- Clifton, NJ3 sgrùdaidhean
Le stàit
- California7 sgrùdaidhean
- Colorado3 sgrùdaidhean
- Florida3 sgrùdaidhean
- Illinois4 sgrùdaidhean
- Kansas3 sgrùdaidhean
- Kentucky3 sgrùdaidhean
- Maryland5 sgrùdaidhean
- Massachusetts3 sgrùdaidhean
- Minnesota3 sgrùdaidhean
- New Jersey4 sgrùdaidhean
- New York4 sgrùdaidhean
- North Carolina5 sgrùdaidhean
- Ohio7 sgrùdaidhean
- Oregon4 sgrùdaidhean
- Pennsylvania5 sgrùdaidhean
- Texas12 sgrùdaidhean
- Washington5 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT04728893CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
A’ fastadhÌre 1/2
Aoisean 3 gu 39 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT05442515A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06542250Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 110 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT00923507Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
A’ fastadhÌre 4
Aoisean 18 gu 130 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06651970Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
A’ fastadhÌre 1
Suas gu aois 75 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT06345027Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
A’ fastadhÌre 3
Aoisean 18 gu 18 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT07509151A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06564038Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)
A’ fastadhÌre 1
12 Months – 25 Years · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT05010564Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
A’ fastadhÌre 2
Aoisean 7 gu 25 · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT05082519A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT05254743ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT07342478A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 31 Iuch 2026 · NCT06708897The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
A’ fastadhÌre 1/2
Aoisean 12 gu 95 · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT04329728A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
A’ fastadhÌre 2
Aoisean 18 gu 66 · Gach gnè · Air ùrachadh 17 Màrt 2026 · NCT06859424A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab
A’ fastadhSgrùdadh amharc
Aoisean 1 gu 23 · Gach gnè · Air ùrachadh 25 Gearr 2026 · NCT07422337Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 22 Faoi 2026 · NCT06357754Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.